proszek do sporządzania roztworu do wstrzykiwań
Sponsors
Merz Pharmaceuticals GmbH, Wroclaw Medical University
Conditions
Lower limb spasticityPediatric lower limb (LL) spasticity (SP) caused by cerebral palsy (CP)Unresectable pancreatic cancer
Phase 3
A prospective, randomized, double-blind, placebo-controlled, two-stage, multicenter study with an open-label extension period to investigate the efficacy and safety of NT 201 in the treatment of lower limb spasticity in children and adolescents with cerebral palsy
CompletedCTIS2023-503420-19-00
Start: 2022-10-12End: 2025-03-04Target: 25Updated: 2024-12-20
Prospective, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy and safety of NT 201 in the treatment of lower limb spasticity caused by stroke or traumatic brain injury in adult subjects, followed by an open label extension with or without combined upper limb treatment
Active, not recruitingCTIS2023-505810-12-00
Start: 2019-09-03Target: 343Updated: 2025-10-29
Effects of calcium electroporation, electrochemotherapy, and irreversible electroporation (IRE-CaCl2, ECT and IRE) on quality of life and progression – free survival in patients with pancreatic cancer" (IREC).
RecruitingCTIS2024-512487-61-00
Start: 2022-02-10Target: 73Updated: 2024-08-09